Direct US stocks vs ETFs: when stock picking makes sense

There's a default piece of advice in personal finance: "Just buy the index. Don't pick individual stocks." It's good advice, and it's right for ~85% of retail investors. But it's not always right.

This post is for the other 15% — the people for whom direct US stock picking has at least a defensible case. We'll walk through when single-stock buying makes sense, when it doesn't, and the specific pitfalls Indian residents hit when they do try.

Why ETFs are the default

Three reasons the index-fund-only advice exists:

1. The math of stock picking is brutal

Hendrik Bessembinder's research showed that of the ~26,000 US public stocks tracked since 1926, only 4% generated all the net wealth above T-bills. The other 96% either underperformed Treasury bills or had near-zero net contribution.

That's stark. The market's long-term return is heavily concentrated in a small number of mega-winners (think Apple, Amazon, Microsoft, Google, NVIDIA — and a few less obvious ones). If you pick a random stock, your most likely outcome is "underperformed safe bonds." The index forces you to own the winners because you own everything.

2. Behavioral mistakes compound

Stock pickers buy after the news, sell after the dip, and reallocate based on recency. The behavior gap (difference between fund returns and investor returns in those funds) is around 1–3% per year for retail investors — larger for stock pickers than for index investors.

Single stocks make this worse. You watch your one stock daily, react to every earnings call, and trade more.

3. Tax friction is higher with stocks

Indian capital gains tax classifies foreign equity as unlisted — slab rate < 24 months, 12.5% LTCG > 24 months. Active stock-picking implies turnover. Turnover triggers tax events. Tax events compound to lower after-tax returns.

A buy-and-hold ETF investor can defer all capital gains for years. A stock picker who turns over their portfolio annually pays tax annually.

When single-stock buying makes sense

That said, there are five real cases where direct stocks have a defensible role:

Case 1: You have informational edge

Not "I read a Bloomberg article" — actual edge. Examples:

• You work in the industry. A pharma scientist has more context on FDA pathways than equity analysts. A semiconductor engineer might understand process node transitions before they're priced in.
• You have early access to product trends. A retail-tech founder who sees small-business adoption patterns ahead of the broader market.
• You're a longtime customer with deep insight. Knowing how a software product really works can be useful (Buffett-style "circle of competence").

This isn't insider trading — that's material non-public information. Edge from observation and pattern-matching is fair game.

The check: can you write down your thesis in 200 words and have it survive 5 years of re-reading? If yes, maybe. If your thesis is "I think AAPL will go up because everyone uses iPhones," that's not edge — it's already priced in.

Case 2: You want exposure to a specific company that ETFs underweight

Example: NVIDIA in 2020. Even if you held VTI, NVIDIA was only ~2% of your portfolio. Capturing the full 10x run from 2020–2025 required overweighting the stock specifically.

This is "concentration as a feature, not a bug." If you have both a high-conviction view AND a willingness to be wrong, single-stock allocation makes sense.

Sizing rule: never put more than 10–15% of your equity in any single stock outside your core ETFs. The asymmetric upside doesn't justify the asymmetric downside if it's larger.

Case 3: You enjoy the process

Some people genuinely enjoy reading 10-Ks and following earnings calls. If that's you, treating 5–15% of your portfolio as "active" is reasonable — both as entertainment and to scratch the itch.

The catch: budget the active portion. The other 85–95% goes into ETFs no matter what. The active sleeve doesn't get to grow into the core if you have a good year.

Case 4: You want concentrated US tech exposure beyond QQQM

If you specifically want to own the "Magnificent 7" or a similar handful of US tech leaders at higher weights than even QQQM offers, building a small custom portfolio of 5–10 stocks works.

But this is mostly a tilt expressible via ETFs (QQQM gives you 10% NVIDIA alone). Direct ownership only adds value if you want concentration beyond what QQQM offers.

Case 5: Tax-loss harvesting precision

This is more advanced. With single stocks, you can sell specific lots at a loss to offset other gains. ETFs don't give you the same per-stock granularity.

For most retail investors, this isn't worth the complexity. For investors with ₹2 cr+ in foreign equity and active gain/loss management, it can save real tax dollars.

When single-stock buying does NOT make sense

The flip side. Five clear cases where you should not:

Anti-case 1: You're new to investing

The first 5 years of investing should be about building habits: regular contributions, riding through downturns, sticking with a plan. Stock picking adds excitement and increases the chance you abandon the plan.

Get the boring foundation in place first. Stock pickers with a 5-year ETF base outperform stock pickers without one, mostly because they don't blow up.

Anti-case 2: You're investing under ₹5 lakh in US equity

The fixed costs of US stock picking — research time, tax compliance, potential losses from concentrated bets — are roughly the same whether you have ₹5 lakh or ₹50 lakh deployed. At ₹5 lakh, the costs dominate any potential alpha.

Get to at least ₹15–20 lakh in core ETFs before considering an active stock sleeve.

Anti-case 3: You only have time once a quarter

Stock picking doesn't require constant attention, but it does require regular attention. If you're not going to read at least the quarterly report and one independent analysis per company per quarter, you're not picking stocks — you're gambling.

Either commit time, or stick with ETFs.

Anti-case 4: Your "thesis" is "the stock has been going up"

Momentum chasing. The stock you're considering has rallied 80% over the last year and you want in. This works until it doesn't, and the reversal is brutal. Buying after a major rally is the highest-variance entry point.

If you genuinely have a forward thesis, it should be valid even if the stock is down 30% from peak. If the thesis only works at recent highs, it's not a thesis.

Anti-case 5: Concentration risk from RSUs

If you already hold ₹30 lakh of your employer's stock from RSUs, don't also pick more single tech stocks. You're already concentrated. Adding more single-stock exposure compounds risk.

People at Microsoft buying NVIDIA. People at Google buying Meta. The sector overlap with your job is significant — you're triply concentrated (employer stock, sector, currency).

Specific Indian-investor pitfalls

Beyond the universal stock-picking issues, Indians face some specific problems:

Pitfall 1: ADRs and OTC stocks not available

Many international companies trade only as ADRs (American Depositary Receipts) — e.g., TSMC (TSM), ASML, Alibaba (BABA), or as OTC. Vested and INDmoney often don't support ADRs or OTC stocks. You may have access to AAPL, MSFT, NVDA but not TSM.

If your stock-picking thesis requires international exposure (TSMC for semis, ASML for chip tools), check first that your platform supports it.

Pitfall 2: Mid-cap and small-cap US stocks

Even mid-cap US stocks (market cap $2-10B) often aren't on Indian platforms. The curated lists focus on large-caps. If you want to invest in smaller US companies, you typically need IBKR.

Pitfall 3: Reporting complexity per stock

Each stock you hold becomes a Schedule FA disclosure. 5 stocks = 5 entities to report. 20 stocks = 20 entities, with peak value, closing balance, and dividend income for each.

ETFs are one entity each. The reporting overhead of single stocks scales linearly with number of holdings.

Pitfall 4: Currency timing on entry/exit

For a buy-and-hold ETF investor, currency averages out over decades. For an active stock picker who enters and exits positions in 1–2 years, currency moves can dominate the trade.

If you bought a stock at ₹83/USD and sold at ₹80/USD, you lost 3.6% from currency on a flat trade. That's the difference between a "winning" trade and a "losing" one before any stock movement.

Pitfall 5: Dividend tax friction on individual stocks

Single-stock dividends require Form 67 filings for FTC, INR conversion at SBI TT-buying rates, and tracking. ETF dividends require the same, but in one ETF, not 10 stocks.

This is just operational overhead — not insurmountable, but worth pricing in.

A reasonable hybrid: 80/20 ETF + active

If you want to dabble in stock picking responsibly, here's a structure that limits damage:

Portion	Allocation	Strategy
Core (always invested)	80% of US equity	VTI + QQQM + VEA. Buy-and-hold.
Active sleeve	20% of US equity	3–7 individual stocks. Active management.

Rules for the active sleeve:

1. Maximum 5% of total US allocation in any single name.
2. Maximum 7 names total.
3. Each name has a written thesis with re-evaluation triggers.
4. Sells are tax-aware (prefer >24 months for LTCG).
5. Rebalance: any single position over 8% of total US allocation gets trimmed back to 5%.

The active sleeve gives you the entertainment and upside of stock picking without exposing your core.

A worked example

Suppose you have ₹40 lakh in US equity. You decide to run an 80/20 hybrid.

Core (₹32 lakh):

• VTI: ₹22.4 lakh (70% of core)
• QQQM: ₹4.8 lakh (15%)
• VEA: ₹4.8 lakh (15%)

Active (₹8 lakh):

• 3 individual companies, ₹2.5–3 lakh each. Names you genuinely have conviction on.
• Maximum any single position: 8 lakh × 25% = ₹2 lakh per name.

If one of your active picks doubles to ₹4 lakh while the others stay flat, your total active is now ₹10 lakh, of which ₹4 lakh is the winner. That's 40% of active, way over your 5%-of-US-allocation rule. Trim it back.

The discipline matters. Without it, "active sleeve" becomes "concentrated bet that ate the portfolio."

The five-question filter

Before buying any single stock, run through:

1. Do I have informational edge that's not already priced in?
2. Is my position size below 5% of total US allocation?
3. Have I written a thesis I can re-read in 3 years?
4. Do I have a sell rule (price target, thesis-break trigger, or holding-period rule)?
5. Will buying this push my total single-stock concentration above 25%?

If you answer "no, I don't really know" to any of these, default back to ETFs.

The summary

For 85% of Indian retail investors: don't pick stocks. Hold VTI/VOO + VEA + a Nifty fund. Spend the time you would have spent on stock research on increasing your savings rate instead.

For the 15% who genuinely want to: 80/20 hybrid. Disciplined sizing. Written theses. Long-term tax efficiency.

Single-stock investing isn't bad in itself. It's bad when it replaces the boring core that's actually doing the work.